Citation Impact
Citing Papers
LIM Protein KyoT2 Negatively Regulates Transcription by Association with the RBP-J DNA-Binding Protein
1998 StandoutNobel
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
2004 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL
2010 StandoutNobel
Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice
2002
Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
1995
Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia
2010
Defects of the Mismatch Repair Gene MSH2 Are Implicated in the Development of Murine and Human Lymphoblastic Lymphomas and Are Associated With the Aberrant Expression of Rhombotin-2 (Lmo-2) and Tal-1 (SCL)
1997
Physical interaction of the bHLH LYL1 protein and NF-κB1 p105
1999
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
2002
The T Cell Leukemia Oncoprotein SCL/tal-1 Is Essential for Development of All Hematopoietic Lineages
1996
Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.
1994
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial
2003
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells
2015
Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future
2007
Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy
2006
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Molecular classification of T-cell lymphomas
2009
Secondary leukemias induced by topoisomerase-targeted drugs
1998
Childhood acute lymphoblastic leukaemia – current status and future perspectives
2001
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
2000
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
2008 Standout
Acute lymphoblastic leukaemia
2013
Network medicine: a network-based approach to human disease
2010 Standout
Regulation of lymphocyte development by Notch signaling
2007 StandoutNobel
Pegaspargase: a review of clinical studies
2003
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
2016 Standout
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
2009
Polymer conjugates as anticancer nanomedicines
2006 Standout
Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia
2002
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
1999
Regulation of cancer cell metabolism
2011 Standout
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Graft-versus-host disease
2009 Standout
Clinical significance of early T‐cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children’s Cancer Study Group Study L99‐15
2011
Sickle-cell disease
2010 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
Mechanisms of angiogenesis
1997 StandoutNature
Childhood Leukemias
1995
Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia
2004
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Major Hematologic Diseases in the Developing World— New Aspects of Diagnosis and Management of Thalassemia, Malarial Anemia, and Acute Leukemia
2001
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
2006
Treatment of Acute Lymphoblastic Leukaemia
2007
Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
2001 Standout
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
2000 StandoutNature
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
L‐asparaginase treatment in acute lymphoblastic leukemia
2010
Advances in the understanding of susceptibility to treatment‐related acute myeloid leukaemia
2007
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
A Bayesian method for the induction of probabilistic networks from data
1992 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy
1992
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Varicella-zoster virus
1996 Standout
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
VENO-OCCLUSIVE DISEASE OF THE LIVER
1955
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
2002
Pten is essential for embryonic development and tumour suppression
1998 Standout
PMS2 endonuclease activity has distinct biological functions and is essential for genome maintenance
2010 StandoutNobel
Cancer treatment and survivorship statistics, 2016
2016 Standout
ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach.
2000
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Asparagine Synthetase Chemotherapy
2006
Molecular Genetics of Acute Lymphoblastic Leukemia
2005
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome
2002
Hematopoietic-Specific Genes Are Not Induced During In Vitro Differentiation of scl-Null Embryonic Stem Cells
1997
Data Mining: Practical Machine Learning Tools and Techniques
2011 Standout
The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse.
1996
Metal–Organic Frameworks in Biomedicine
2011 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
A Bayesian Method for the Induction of Probabilistic Networks from Data
1992 Standout
Data mining: concepts and techniques
2012 Standout
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
2006
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)
2005
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding
1999
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of M Amylon being referenced
Probabilistic Prediction of the Outcome of Bone-Marrow Transplantation
1989
Does activation of the TAL1 gene occur in a majority of patients with T- cell acute lymphoblastic leukemia? A pediatric oncology group study
1995
Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study
1993
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report
2000
Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study.
1998
Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia.
1991
Bone Marrow Transplantation in Thalassemia: A Role for Radiation?
1998
Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia.
1995
Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies
2000
Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study
1999
Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants
1999
Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin
1984
Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
1991
Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study
1999
Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study
1993
Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro.
1999